View Cart  

Study Finds FDA, CMS Regularly Miss Mandatory Review Timelines

A A
The FDA and Centers for Medicare and Medicaid Services (CMS) continue to struggle — and often fail — to meet statutory deadlines for approving Class III devices and issuing national coverage decisions (NCD), according to a paper in the October issue of Health Affairs that looked at median approval times since the mid-1990s.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00